Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.
EnVision Endoscopy is a medical device that provides endoscopic surgeries with solutions.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
99C manufactures build-to-order apparel for the growing e-commerce market and serves as an economic mobility bridge for the local.
Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.
Haystack Dx developed a complete solution to address the clinical unmet need to improve the diagnostic procedure for neuromuscular disorder.
Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.
New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI.
Snapdragon Chemistry focus on developing practical manufacturing solutions for challenging chemical transformations.
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases.
Virex is a biotechnology firm that enables widespread testing in life, homes, workplaces, schools, and public spaces globally.
LUMMÉ's AI-powered smartwatch apps continuously monitor, predict and steer high frequency behaviors such as eating and smoking.
149 Medical provides non-invasive tools to monitor and measure real-time brain hemodynamics and metabolism in preterm newborns.
Nutrimedy defining telenutrition through novel online platform based on the integration of leading edge science, technology & health.
UrSure is a medication adherence company based in Boston, Massachusetts.
Flaskworks is improves the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
Gloucester Marine Genomics Institute addresses critical challenges facing oceans, human health and the environment.
Lariat Biosciences is an employee-owned biotechnology start-up.
Insightfil enables pharmacies to offer personalized care to their patients, increasing pharmacy profits while improving patient health.
Institute for Protein Innovation (IPI) is pioneering a new approach to scientific discovery and collaboration.
Firefly BioWorks offers an open platform for industrial, academic, and clinical scientists to develop and use multiplexed biological assays.
Massachusetts Life Sciences Center has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Massachusetts Life Sciences Center's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical. The firm invests across 26 different industry categories.
Among tracked funding rounds, Paragonix Technologies received $24.0M in a Series B round. Massachusetts Life Sciences Center's total known invested capital is $229.7M.
Massachusetts Life Sciences Center's average investment size is $5.7M across its portfolio of 46 companies.
Recent Massachusetts Life Sciences Center portfolio additions include Lucy Therapeutics, EnVision Endoscopy, Reveal Pharmaceuticals, Paragonix Technologies, 99degrees Custom. These companies were founded in 2020 or later.